Community Academic Profiles–

Michael Link

Back to Profile

Publication Details

  • Use of an anti-ALK antibody in the characterization of anaplastic large-cell lymphoma of childhood.

    Hutchison RE, Banki K, Shuster JJ, Barrett D, Dieck C, Berard CW, Murphy SB, Link MP, Pick TE, Laver J, Schwenn M, Mathew P, Morris SW. Ann Oncol. 1997: 8 Suppl 1 37-42

    Anaplastic lymphoma kinase (ALK) is a tyrosine kinase inappropriately expressed in lymphoid tissue involved by CD30+ anaplastic large-cell lymphoma (ALCL) with the translocation t(2;5)(p23;q35)(, which juxtaposes the nucleophosmin gene (NPM) with that encoding ALK, resulting in a hybrid (NPM-ALK) message.

    PubMedID: 9187427

Stanford Medicine Resources:

Footer Links: